Winton Group’s Impax Laboratories, Inc. IPXL Stock Holding History

Winton Group’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-424,501	Closed	-$8.26M	–	1234
2018 Q1	$8.26M	Sell	424,501 -28,831	-6%	-$566K	0.23%	109
2017 Q4	$7.55M	Buy	453,332 +286,822	+172%	+$5.26M	0.22%	127
2017 Q3	$3.38M	Buy	166,510 +100,304	+152%	+$1.92M	0.11%	218
2017 Q2	$1.07M	Buy	+66,206	New	+$978K	0.03%	339

Winton Group's IPXL Position: Q2 2018 in Review

Winton Group sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 424,501 shares — an estimated $8.26M sold.

Winton Group first reported a position in IPXL in Q2 2017 and held it in 4 quarters. The position peaked at $8.26M in Q1 2018. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.

Winton Group reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
Winton Group sold 424,501 Impax Laboratories, Inc. shares in Q2 2018, an estimated $8.26M.
Winton Group first reported a position in Impax Laboratories, Inc. in Q2 2017 and held it in 4 quarters.
Winton Group's Impax Laboratories, Inc. position peaked at $8.26M in Q1 2018.
1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.

Based on Winton Group's 13F filing for Q2 2018, filed 20 Aug 2018.